Drugs / Infanrix IPV
Infanrix IPV
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00463437 | Apr 2007 → Jan 2008 | diphtheria, hepatitis B virus infection, pneumococcal infection, poliomyelitis +1 | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00290342 | Jan 2006 → Jan 2007 | diphtheria, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01277705 | Jan → Apr 2002 | diphtheria, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT01309646 Comparator | Mar 2011 → Feb 2012 | diphtheria, haemophilus infectious disease, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00586612 Background | Dec 2007 → Dec 2008 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00454987 Background | May → Oct 2007 | haemophilus meningitis, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix IPV | “Menitorix™ and Infanrix IPV™ or Meningitec™ and Pediacel™ in infancy.” NCT00454987 ↗ |
| Known as | Boostrix-polio | “received a single decennial booster dose of dTpa-IPV (Boostrix-polio, GlaxoSmithKline Vaccines).” PMID 25882172 ↗ Apr 2015 |
| Known as | dTpa-IPV | “A new combined reduced-antigen-content dTpa-IPV vaccine provides booster vaccination against all four diseases in one single injection.” PMID 15882526 ↗ May 2005 |
| Modality | Vaccine | “combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus (DTPa-IPV) vaccine” NCT00290342 ↗ |
| Route | Intramuscular | “received 3 doses of the GSK Biologicals' combined Infanrix™-IPV (DTPa-IPV) vaccine at 2, 4 and 6 months of age, intramuscularly into the antero-lateral thigh” NCT00290342 ↗ |